Edition:
United States

Baxter International Inc (BAX)

BAX on New York Consolidated

49.96USD
21 Feb 2017
Change (% chg)

$0.23 (+0.46%)
Prev Close
$49.73
Open
$49.75
Day's High
$50.20
Day's Low
$49.59
Volume
3,427,339
Avg. Vol
3,628,338
52-wk High
$50.20
52-wk Low
$37.69

BAX

Chart for BAX

About

Baxter International Inc., through its subsidiaries, provides a portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics, and pharmacy automation, software and... (more)

Overall

Beta: 0.78
Market Cap(Mil.): $27,049.14
Shares Outstanding(Mil.): 543.92
Dividend: 0.13
Yield (%): 1.05

Financials

  BAX Industry Sector
P/E (TTM): 5.53 34.21 29.32
EPS (TTM): 9.00 -- --
ROI: -- 12.42 13.03
ROE: -- 14.41 14.17

BRIEF-Baxter debuts enteral nutrition ENFit syringe and accessory line in clinical nutrition week 2017

* Baxter debuts enteral nutrition ENFit syringe and accessory line during clinical nutrition week 2017

Feb 16 2017

BRIEF-Baxter appoints Stephen Oesterle to its board

* Appointment brings total number serving on board to 12 Source text for Eikon: Further company coverage:

Feb 08 2017

Siemens to pick banks for blockbuster Healthineers listing: sources

FRANKFURT German industrial group Siemens will shortly start picking banks to organize a stock market listing of its healthcare business, which could be valued at up to 37 billion euros ($40 billion) including debt, three people close to the matter said.

Jan 25 2017

BRIEF-Baxter's renal therapy services significantly reduced peritonitis infections among home dialysis patients

* Baxter's renal therapy services significantly reduced peritonitis infections among home dialysis patients

Jan 19 2017

Baxter to pay $18 million over mold at North Carolina plant

WASHINGTON Baxter International has agreed to pay $18 million to resolve its criminal and civil liability over claims its unit ignored mold in air filters at a plant where sterile intravenous solutions were made, the U.S. Justice Department said on Thursday.

Jan 12 2017

UPDATE 2-Baxter to pay $18 mln over mold at North Carolina plant

WASHINGTON, Jan 12 Baxter International has agreed to pay $18 million to resolve its criminal and civil liability over claims its unit ignored mold in air filters at a plant where sterile intravenous solutions were made, the U.S. Justice Department said on Thursday.

Jan 12 2017

BRIEF-Baxter presented exploratory research on the removal of inflammation-related molecules during extracorporeal blood purification therapy

* Baxter International Inc - presented exploratory research on the removal of inflammation-related molecules during extracorporeal blood purification therapy

Nov 22 2016

BRIEF-Baxter declares quarterly dividend and announces expanded share repurchase authorization

* Baxter declares quarterly dividend and announces expanded share repurchase authorization

Nov 08 2016

BRIEF-Baxter Q3 adj earnings per share $0.56 from continuing operations excluding items

* Baxter reports third quarter 2016 results and increases financial outlook for full-year 2016

Oct 25 2016

Fitch Affirms Baxter International Inc.'s IDR at 'BBB+'; Outlook Stable

(The following statement was released by the rating agency) CHICAGO, October 03 (Fitch) Fitch Ratings has affirmed Baxter International Inc.'s (BAX/Baxter) Long-Term Issuer Default Rating at 'BBB+'. The Rating Outlook is Stable. Baxter had approximately $3.2 billion in outstanding debt at June 30, 2016. A full list of Baxter's ratings follows at the end of this release. KEY RATING DRIVERS --The 'BBB+' rating reflects Baxter's significant deleveraging and strong operating performance post th

Oct 03 2016

More From Around the Web

Earnings vs. Estimates